Product Information
OCTREOTIDE ACET 100 MCG/ML VL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $2.5346 per ML under NDC 63323037604. Its NADAC has been published 120 times since Jun 19, 2024.
FDA first approved this application on Feb 10, 2006. Its Orange Book therapeutic-equivalence code is AP.
Strength
100 ug/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323037604
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
OCTREOTIDE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA077457FDA Approved
2/10/2006
TE Code
AP
On Market Since
3/14/2006
Pharmacological Classes
Price Statistics
The NADAC for OCTREOTIDE ACET 100 MCG/ML VL has been published 120 times since Jun 19, 2024, and over the history we have for it it has declined 37.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5346 per ML |
|---|---|
| All-time high | $4.0231 (Jul 10, 2024) |
| All-time low | $2.4097 (Aug 19, 2026) |
| 52-week high | $3.0604 |
| 52-week low | $2.4097 |
| Median price | $2.8760 |
| Average price | $2.9793 |
| Largest weekly change | -11.7% (Jul 17, 2024) |
| Weeks tracked | 120 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
OCTREOTIDE ACETATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Somatostatin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OCTREOTIDE ACET 100 MCG/ML VL?
The current National Average Drug Acquisition Cost (NADAC) for OCTREOTIDE ACET 100 MCG/ML VL, manufactured by Fresenius Kabi USA, LLC, is $2.5346 per ML (NDC 63323037604), effective Sep 30, 2026.
How has the price of OCTREOTIDE ACET 100 MCG/ML VL changed over time?
Over the history we have for it, the NADAC for OCTREOTIDE ACET 100 MCG/ML VL has declined 37.0%. It has been tracked across 120 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for OCTREOTIDE ACET 100 MCG/ML VL?
Since Jun 19, 2024, the NADAC for OCTREOTIDE ACET 100 MCG/ML VL has ranged from a low of $2.4097 (Aug 19, 2026) to a high of $4.0231 (Jul 10, 2024), with a median of $2.8760 per ML.
Are there cheaper alternatives to OCTREOTIDE ACET 100 MCG/ML VL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as OCTREOTIDE ACET 100 MCG/ML VL in a comparable dosage form, but none are currently priced below it.
Who manufactures OCTREOTIDE ACET 100 MCG/ML VL?
OCTREOTIDE ACET 100 MCG/ML VL (NDC 63323037604) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.